Vaidya Sane Ayurved Laboratories Limited · NSE:MADHAVBAUG
Vaidya Sane Ayurved Laboratories — FY2023 Earnings Presentation
41 slides from Vaidya Sane Ayurved Laboratories's earnings presentation, May 29, 2023
Slide 1: NSE filing cover letter - Investor Presentation
Date: 29th May 2023 To, Listing Compliance Department, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai-400051 NSE Symbol: Madhavbaug Sub: Investor Presentation Please find attached Investor Presentation based on the Financial & operational performa
Slide 2: Vaidya Sane Ayurved Laboratories Ltd. Investor Presentation May 2023
Vaidya Sane Ayurved Laboratories Ltd. Investor Presentation May 2023
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Vaidya Sane Ayurved Laboratories Limited (the “Company”) solely for information purposes and does not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in conn
Slide 4: Table of Contents
V a = of Contents a Company Overview foal (w) Business Overview Industry Overview (@) Financial Highlights Way Ahead Madhavbaug Multcisciolinary Cardiac Care Clinics & Hospitals
Slide 5: Company Overview
Company Overview aes = 2s
Slide 6: About Us
About Us Among leading chains of Cardiac care clinics & Hospitals Unique medical service institution – focus on Traditional Medicine Strives to reduce India’s disease burden of Cardiac disease, Diabetes, Hypertension and Obesity Madhavbaug has 302 Clinics Across India Treatments Rural reach
Slide 7: Company Structure
Company Structure Vaidya Sane Ayurved Laboratories Ltd. “F-Health Accelerators “Cure and Care Primary Care “Easy Ayurveda Private “Madhavbaug Health Food Private Limited” Private Limited” Limited” Supplements Trading Co. (80% Holding) (Raphacure – 17.5% Holding) (15% Holding) LLC” Focus on start-u
Slide 8: 9th World Ayurveda Congress at Panjim, Goa
9th World Ayurveda Congress at Panjim, Goa Second Time Prime Sponsor of 9th World Ayurveda Congress & Arogya Expo was organized with focal theme “Ayurveda for One Health” at Panjim, Goa Arogya Expo was inaugurated by Dr. Pramod Sawant, Chief Minister of Goa Honorable Prime Minister Shri. Naren
Slide 9: Madhavbaug's 360 Degree Ecosystem
Madhavbaug’s 360 Degree Ecosystem Holistic Treatment Methodology leading to objective results Assessment & Screening Using Modern Diagnostics to provide accurate results - ECG, Stress Test, 2D Echo, Blood Investigations, CT Researched diets, tested lifestyle modifications Angiography etc. techniques
Slide 10: Journey So Far
Journey So Far 2006 - 1st Cardiac 2014 - Arogyam Hriday 2018 - India book record Listing of shares on NSE-Emerge Hospital in Khopoli Sampada launched for conducting GTT of 661 Khopoli Hospital empanelment with SBI General Insurance and opening of 1st with Mission to create patient in singl
Slide 11: Strong & Experienced Management
Strong & Experienced Management Dr. Rohit Sane MBBS (Medicine and Surgery) and fellowship in Cardiac Rehabilitation (Managing Director More than 20 years of experience in health care consulting & CEO) Pioneer in conceptualizing and promoting Ayurveda in healing of chronic heart diseases - Samp
Slide 12: Strong & Experienced Management
Strong & Experienced Management BAMS, MD (Samhita, Siddhant), PGDEMS and Certified Black belt in Six Sigma Affiliated with Madhavbaug since 2007, worked on various levels in medical operations, and Dr. Gurudatta Amin Designated as CMO since 2012 (Chief Medical Officer) Designed Medical Strateg
Slide 13: Key Strengths
Key Strengths Strong Research based Treatments & Therapies with papers published and accepted internationally Unique combination of modern healing methods and ancient natural practices Experienced Leadership with able & well-trained team led by Dr. Rohit Madhav Sane Effective, Non- Invasive & Afford
Slide 14: Business Overview
~ 02 Business Overview
Slide 15: Madhavbaug's Unique Model
Madhavbaug’s Unique Model Business Clinic Revenue Model Model FY23 Revenue: Rs. 152.84 Cr Hospitals Clinics Services Products *Revenue : Rs. 29.52 Cr *Revenue : Rs. 152.84 Cr *Revenue : Rs. 90.25 Cr *Revenue : Rs. 62.59 Cr Hospitals, Products, 16.19% 40.95% Clinics, 83.81% Services, 59.05% *
Slide 16: Holistic Treatment Programs
Holistic Treatment Programs Secondary Prevention & Rehabilitation Programs: Plaque Stabilization Therapy (PST) Treatment Programs Diabetic Complication Management (DHCM) Heart Failure Reversal Therapy (HFRT) Hypertensive Complication Management (HCM) Ischemia Reversal Programme (IRP) Tot
Slide 17: …with Innovative Reversal Therapies…
…with Innovative Reversal Therapies… Heart Disease Diabetes Blood Pressure Obesity Reversal Reversal Management Management Cardioprotective Therapy Comprehensive Diabetic Care Blood Pressure Management Obesity Management Ischemic Reversal Program Program Program Program CAD Management
Slide 18: …with Pan India Network as on 31st Mar' 2023
…with Pan India Network as on 31st Mar’ 2023 Utter Pradesh 15 Clinics Gujrat 17 Clinics Maharashtra Madhya Pradesh 224 Clinics 19 Clinics Chhattisgarh Goa 3 Clinics 3 Clinics Karnataka Madhavbaug Hospital Khopoli, 20 Clinics Madhavbaug Hospital Kondhali Kerala 1 Clinics 15
Slide 19: State of Art Hospitals - Khopoli & Nagpur, Maharashtra
State of Art Hospitals - Khopoli & Nagpur, Maharashtra Khopoli Hospital (Revenue in Rs. Cr) Madhavbaug Hospital Khopoli – 1st Hospital in 2006 22.77 Madhavbaug Hospital Kondhali, Nagpur – 2nd Hospital in 2012 19.35 2 Hospitals - Team of 450+ Doctors clinics Expert Doctors FY22 FY23 Advance
Slide 20: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics 19
Slide 21: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics No. of Clinics (Ownershipwise) Average Revenue per Clinic (Rs. in Lacs) Clinic Enterprise Revenue (In Rs. Lacs) 33.47% FY22 – 11,451 FY23 – 15,284 302 49.19 9,025 277 6,542 6,259 178 196 4,909 43.21 48 51 49 57 FY22 FY23 FY22 FY23 FY22 FY23 Company Franchise OP
Slide 22: Empanelment with Insurance Companies
Empanelment with Insurance Companies Medi Assist Ericson Insurance TPA Health India Paramount Health More than 30 Insurance companies empaneled with above Third Party Administrators (TPA) each 22
Slide 23: Madhavbaug POWER MAP
Madhavbaug POWER MAP Medical analytics service built for Madhavbaug Doctors to help them reverse Chronic cardiac disease of their patients effectively - Union Minister for Road Transport and Highways Nitin Gadkari inaugurated Madhavbaug's Power MAP on 15th January 2022 Critical Care Diet Man
Slide 24: mib Pulse App - Enable Healthcare reach to lowest strata
mib Pulse App - Enable Healthcare reach to lowest strata It’s a free app which anyone can use from anywhere in case of Medical assistance App gives you full past history of your health MIB Pulse App (+100K Downloads) Medical Assistance Connected Medical Assistance of Doctors to give patients
Slide 25: Madhavbaug's Research based Diet Kits
Madhavbaug’s Research based Diet Kits Diabetes Reversal Heart Disease Reversal Hypertension Reversal Obesity Reversal Breakfast Lunch/Dinner 23
Slide 26: Industry Overview
03 Industry Overview
Slide 27: India's Non-Communicable Disease (NCD) Challenges
India’s Non – Communicable Disease (NCD) Challenges 66% of all death in India caused by Non – Communicable diseases Roughly 77 million Diabetes patients in India India estimated to have 44 million Diabetes 1 million Indians die of Diabetes p.a undiagnosed Diabetes patients India has 135 millio
Slide 28: Higher Stress increasing Diseased population
Higher Stress increasing Diseased population Middle Class Population ( In million) 800.0 400.0 153.0 2010 2020 2030 Working Age Population of India (in million) 665.0 Share of Non-communicable diseases 574.0 463.0 495.0 – Causes of death, India, 2000-22 397.0 62.0% 66.0% 68.0% 70.0% 56.0% 46.0% 2000
Slide 29: Re-emergence of Traditional Medical Care
Re-emergence of Traditional Medical Care Notable trends Market size and services offered Traditional medical sector developing Traditional Knowledge Digital Indian Ayurvedic Industry expected to reach Library to prevent companies from claiming patents on such remedies US$ 9 billion by 2022 - Ayu
Slide 30: Financial Highlights
04 Financial Highlights
Slide 31: Management Comments
Management Comments “I am happy to share that our performance for FY23 performance has been in line with our growth strategies. During the year we have registered a Revenue of Rs. 99.03 crore. EBITDA and PAT were Rs. 8.33 crore and 5.19 crore. The growth in top line was mainly on account of increase
Slide 32: Half Yearly Financial Highlights
Half Yearly Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPDs Khopoli Hospital Kondhali Hospital 53.50 Franchise Company Clinic Mini Clinic 43.15 45.53 97.32 31.36 47.91 19.35 20.19 13.89 11.87 13.19 1.56 5.11 1.97 3.55 0.00 H2 FY22 H2 FY23 H1 FY22 H2 FY22 H1 F
Slide 33: Financial Highlights – Half Yearly
Financial Highlights – Half Yearly Rs. Crore H2 FY23 H2 FY22 Y-o-Y (%) H1 FY23 Income from Operations 53.50 43.15 45.53 Other Operating Income 0.00 0.00 0.00 Revenue from operations for H2 FY23 is Total Income 53.50 43.15 23.99% 45.53 53.50 crs as against Rs. 43.15 crs in H2 Raw Materials 14.56 12
Slide 34: Annual Financial Highlights
Annual Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPDs Khopoli Hospital Kondhali Hospital 99.03 Franchise Company Clinic Mini Clinic 97.32 96.42 75.23 74.71 62.50 52.27 32.27 19.35 22.77 24.11 13.89 5.11 6.75 1.56 1.97 0.00 FY19 FY20 FY21 FY22 FY23 FY22 FY23
Slide 35: Annual Financial Highlights
Annual Financial Highlights Rs. Crore FY23 FY22* Y-o-Y (%) Income from Operations 99.03 74.71 Other Operating Income 0.00 0.00 99.03 74.71 32.55% Revenue from operations for FY23 is Total Income 99.03 crs as against Rs. 74.71 crs in FY22, Raw Materials 27.62 22.07 YoY increase of 32.55% - on accou
Slide 36: Annual Balance Sheet Highlights
Annual Balance Sheet Highlights As on 31st As on 31st As on 31st As on 31st Rs. Crore Rs. Crore Mar’ 23 Mar’ 22* Mar’ 23 Mar’ 22* Shareholder’s Funds 40.81 35.88 Non-current assets 26.46 24.53 Share capital 10.51 10.51 Property, Plant & Equipment Other Equity 30.30 25.37 Tangible assets 18.43 15.96
Slide 37: Key Balance Sheet Ratios
Key Balance Sheet Ratios RoE(%) RoA(%) 9.39% 12.72% 10.50% 6.94% 9.67% 4.02% 3.37% 1.52% 1.30% 0.42% FY19 FY20 FY21 FY22* FY23 FY19 FY20 FY21 FY22* FY23 RoCE(%) 17.76% 17.8% 15.44% 10.75% 7.66% FY19 FY20 FY21 FY22* FY23 * IPO in FY22 to raise Rs. 20.23 crs 35 RoE = Net Profit/Net Worth | RoA = Net P
Slide 38: Way Ahead
a y Way Ahead oe
Slide 39: Way Ahead
Way Ahead Scalable and Standardized Clinic Design Clinic-based health care delivery model along with tele-medicine - low capex requirement and easy accessibility Strengthening and Expanding Clinic and Hospital Network Strategic locations in Maharashtra; expand Clinic Network in Madhya Pradesh, U
Slide 40: Madhavbaug's Mission 2025
Madhavbaug’s Mission 2025 “By 2025, Over 5 Crore People in India will be directly under Madhavbaug’s Care” Clinics & Hospitals Expansion of Khopoli hospital with 60 Save My Heart – App Beds and Kondhali 20 Beds additional Purported for preventation Cashless services to patients at hospitals of
Slide 41: Thank You
THANK YOU For further information, please contact: Mr. Abhishek Deshpande Mr. Amit Sharma / Mr. Rupesh Rege Vaidya Sane Ayurved Laboratories Ltd AdfactorsPR Pvt. Ltd. Tel: +91 9764434693 Tel: +91 98677 26686 /+91 9594918891 Email: cs@Madhavbaug.com Email: amit.sharma@adfactorspr.com/rupesh.rege@adfa
Vaidya Sane Ayurved Laboratories — FY2023 Earnings Presentation on 6ix